Markets › United States › NAS › AMPH

Amphastar Pharmaceuticals Inc

NAS:AMPHHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$24.64−5.38%LiveIn session · ≈ AED 90.49 · Market cap $1.05B · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	41.0%	45.6%	49.9%	54.5%	51.1%	49.5%	—	—
Operating margin	3.1%	16.0%	21.5%	30.6%	28.1%	19.5%	19.5%	+0.0 pts
Net margin	0.4%	14.2%	18.3%	21.3%	21.8%	13.6%	13.6%	+0.0 pts
EBITDA margin	8.6%	25.5%	29.3%	37.3%	37.9%	29.5%	—	—
Return on equity	0.3%	13.9%	17.3%	21.5%	21.8%	12.4%	12.4%	+0.0 pts
Return on assets	0.2%	9.2%	12.3%	9.1%	10.1%	6.0%	6.0%	+0.0 pts
Return on capital employed	2.1%	12.3%	16.6%	15.3%	14.6%	9.5%	—	—
Debt / equity	0.2×	0.2×	0.2×	1.0×	0.9×	0.8×	0.8×	+0.0%
Debt / assets	10.7%	15.6%	13.8%	41.2%	41.2%	40.3%	—	—
Interest coverage	29.3×	79.0×	58.2×	7.3×	6.8×	5.5×	—	—
Current ratio	2.5×	3.1×	4.0×	2.2×	3.1×	4.0×	4.0×	+0.0%
Quick ratio	1.6×	2.2×	2.9×	1.7×	2.2×	2.9×	—	—
Cash ratio	0.8×	1.2×	1.6×	0.6×	0.9×	1.1×	1.1×	+0.0%
Asset turnover	0.6×	0.7×	0.7×	0.4×	0.5×	0.4×	—	—
Inventory turnover	2.1×	2.6×	2.4×	2.8×	2.3×	2.1×	—	—
Receivables turnover	5.3×	5.6×	5.6×	5.6×	5.3×	5.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—